Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Rett Syndrome Mutant Neural Cells Lacks MeCP2 Immunoreactive Bands.

Bueno C, Tabares-Seisdedos R, Moraleda JM, Martinez S.

PLoS One. 2016 Apr 11;11(4):e0153262. doi: 10.1371/journal.pone.0153262. eCollection 2016.

2.

Developmental Dynamics of Rett Syndrome.

Feldman D, Banerjee A, Sur M.

Neural Plast. 2016;2016:6154080. doi: 10.1155/2016/6154080. Epub 2016 Jan 31. Review.

3.

In Sickness and in Health: Perineuronal Nets and Synaptic Plasticity in Psychiatric Disorders.

Pantazopoulos H, Berretta S.

Neural Plast. 2016;2016:9847696. doi: 10.1155/2016/9847696. Epub 2015 Dec 29. Review.

4.

MECP2 Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in Malignancy.

Neupane M, Clark AP, Landini S, Birkbak NJ, Eklund AC, Lim E, Culhane AC, Barry WT, Schumacher SE, Beroukhim R, Szallasi Z, Vidal M, Hill DE, Silver DP.

Cancer Discov. 2016 Jan;6(1):45-58. doi: 10.1158/2159-8290.CD-15-0341. Epub 2015 Nov 6.

5.

Disruption of DNA-methylation-dependent long gene repression in Rett syndrome.

Gabel HW, Kinde B, Stroud H, Gilbert CS, Harmin DA, Kastan NR, Hemberg M, Ebert DH, Greenberg ME.

Nature. 2015 Jun 4;522(7554):89-93. doi: 10.1038/nature14319. Epub 2015 Mar 11.

6.

Fetal alcohol exposure alters proopiomelanocortin gene expression and hypothalamic-pituitary-adrenal axis function via increasing MeCP2 expression in the hypothalamus.

Gangisetty O, Bekdash R, Maglakelidze G, Sarkar DK.

PLoS One. 2014 Nov 19;9(11):e113228. doi: 10.1371/journal.pone.0113228. eCollection 2014.

7.

Cell-type-specific repression by methyl-CpG-binding protein 2 is biased toward long genes.

Sugino K, Hempel CM, Okaty BW, Arnson HA, Kato S, Dani VS, Nelson SB.

J Neurosci. 2014 Sep 17;34(38):12877-83. doi: 10.1523/JNEUROSCI.2674-14.2014.

8.

Microglia as a critical player in both developmental and late-life CNS pathologies.

Derecki NC, Katzmarski N, Kipnis J, Meyer-Luehmann M.

Acta Neuropathol. 2014 Sep;128(3):333-45. doi: 10.1007/s00401-014-1321-z. Epub 2014 Jul 24. Review.

9.

GluD1 is a common altered player in neuronal differentiation from both MECP2-mutated and CDKL5-mutated iPS cells.

Livide G, Patriarchi T, Amenduni M, Amabile S, Yasui D, Calcagno E, Lo Rizzo C, De Falco G, Ulivieri C, Ariani F, Mari F, Mencarelli MA, Hell JW, Renieri A, Meloni I.

Eur J Hum Genet. 2015 Feb;23(2):195-201. doi: 10.1038/ejhg.2014.81. Epub 2014 Jun 11.

10.

Non-coding RNAs in chromatin disease involving neurological defects.

Della Ragione F, Gagliardi M, D'Esposito M, Matarazzo MR.

Front Cell Neurosci. 2014 Feb 25;8:54. doi: 10.3389/fncel.2014.00054. eCollection 2014. Review.

11.

Global transcriptional and translational repression in human-embryonic-stem-cell-derived Rett syndrome neurons.

Li Y, Wang H, Muffat J, Cheng AW, Orlando DA, Lovén J, Kwok SM, Feldman DA, Bateup HS, Gao Q, Hockemeyer D, Mitalipova M, Lewis CA, Vander Heiden MG, Sur M, Young RA, Jaenisch R.

Cell Stem Cell. 2013 Oct 3;13(4):446-58. doi: 10.1016/j.stem.2013.09.001.

12.

Drug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet syndrome treatment.

Baraban SC, Dinday MT, Hortopan GA.

Nat Commun. 2013;4:2410. doi: 10.1038/ncomms3410.

13.

Promoter-like sequences regulating transcriptional activity in neurexin and neuroligin genes.

Runkel F, Rohlmann A, Reissner C, Brand SM, Missler M.

J Neurochem. 2013 Oct;127(1):36-47. doi: 10.1111/jnc.12372. Epub 2013 Aug 21.

14.

BDNF deregulation in Rett syndrome.

Li W, Pozzo-Miller L.

Neuropharmacology. 2014 Jan;76 Pt C:737-46. doi: 10.1016/j.neuropharm.2013.03.024. Epub 2013 Apr 15. Review.

15.

Impaired in vivo binding of MeCP2 to chromatin in the absence of its DNA methyl-binding domain.

Stuss DP, Cheema M, Ng MK, Martinez de Paz A, Williamson B, Missiaen K, Cosman JD, McPhee D, Esteller M, Hendzel M, Delaney K, Ausió J.

Nucleic Acids Res. 2013 May;41(9):4888-900. doi: 10.1093/nar/gkt213. Epub 2013 Apr 4.

16.

2012 William Allan Award: Adventures in cytogenetics.

Francke U.

Am J Hum Genet. 2013 Mar 7;92(3):325-37. doi: 10.1016/j.ajhg.2013.01.010. No abstract available.

17.

MeCP2 modulates gene expression pathways in astrocytes.

Yasui DH, Xu H, Dunaway KW, Lasalle JM, Jin LW, Maezawa I.

Mol Autism. 2013 Jan 25;4(1):3. doi: 10.1186/2040-2392-4-3.

18.

Correcting deregulated Fxyd1 expression ameliorates a behavioral impairment in a mouse model of Rett syndrome.

Matagne V, Budden S, Ojeda SR, Raber J.

Brain Res. 2013 Feb 16;1496:104-14. doi: 10.1016/j.brainres.2012.12.009. Epub 2012 Dec 14.

19.

Depression in pregnancy, infant birth weight and DNA methylation of imprint regulatory elements.

Liu Y, Murphy SK, Murtha AP, Fuemmeler BF, Schildkraut J, Huang Z, Overcash F, Kurtzberg J, Jirtle R, Iversen ES, Forman MR, Hoyo C.

Epigenetics. 2012 Jul;7(7):735-46. doi: 10.4161/epi.20734. Epub 2012 Jul 1.

20.

Linking epigenetics to human disease and Rett syndrome: the emerging novel and challenging concepts in MeCP2 research.

Zachariah RM, Rastegar M.

Neural Plast. 2012;2012:415825. doi: 10.1155/2012/415825. Epub 2012 Feb 9. Review.

Items per page

Supplemental Content

Write to the Help Desk